We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · November 16, 2020

Activity of Sirolimus in Patients With Progressive Epithelioid Hemangioendothelioma



Additional Info

Activity of Sirolimus in Patients With Progressive Epithelioid Hemangioendothelioma: A Case-Series Analysis Within the Italian Rare Cancer Network
Cancer 2020 Oct 27;[EPub Ahead of Print], S Stacchiotti, N Simeone, S Lo Vullo, GG Baldi, A Brunello, B Vincenzi, E Palassini, G Dagrada, P Collini, C Morosi, FG Greco, M Sbaraglia, AP Dei Tos, L Mariani, AM Frezza, PG Casali

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading